Correlation Between Gossamer Bio and MEI Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gossamer Bio and MEI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gossamer Bio and MEI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gossamer Bio and MEI Pharma, you can compare the effects of market volatilities on Gossamer Bio and MEI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gossamer Bio with a short position of MEI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gossamer Bio and MEI Pharma.

Diversification Opportunities for Gossamer Bio and MEI Pharma

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Gossamer and MEI is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Gossamer Bio and MEI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEI Pharma and Gossamer Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gossamer Bio are associated (or correlated) with MEI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEI Pharma has no effect on the direction of Gossamer Bio i.e., Gossamer Bio and MEI Pharma go up and down completely randomly.

Pair Corralation between Gossamer Bio and MEI Pharma

Given the investment horizon of 90 days Gossamer Bio is expected to under-perform the MEI Pharma. In addition to that, Gossamer Bio is 1.47 times more volatile than MEI Pharma. It trades about -0.05 of its total potential returns per unit of risk. MEI Pharma is currently generating about -0.05 per unit of volatility. If you would invest  415.00  in MEI Pharma on August 27, 2024 and sell it today you would lose (137.00) from holding MEI Pharma or give up 33.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Gossamer Bio  vs.  MEI Pharma

 Performance 
       Timeline  
Gossamer Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gossamer Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
MEI Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MEI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Gossamer Bio and MEI Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gossamer Bio and MEI Pharma

The main advantage of trading using opposite Gossamer Bio and MEI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gossamer Bio position performs unexpectedly, MEI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will offset losses from the drop in MEI Pharma's long position.
The idea behind Gossamer Bio and MEI Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance